GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
3.4k
c/trialwatch·posted 1 year ago by u/nils_tulloch

three years of SELECT threads, summarised so you do not have to read them

Paper Receipts ×2 Slow Clap ×3 Well Actually ×1

Right, the SURMOUNT question again, but with numbers this time.

I have 2 data points over 30 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign.

The thing I would flag for anyone new: the effect I am describing showed up at week 46, not week 95. People give up long before the interesting part.

Interested in whether this matches other people's logs or whether I am an outlier.

3,508 up / 119 down97% upvoted68 commentsid 5ix5a920 Mar 2025

68 comments

30 in this archive, depth 5

best — the order this archive was captured in

u/hugo_norgaard712 points·1 year ago
i have this exact spreadsheet
replysharereportpermalink
u/alcohol_aversion590 points·1 year ago

Yeah, absolute numbers matter more than the press release.

replysharereportpermalink
u/camila_vasquez134 points·1 year ago

absolute risk reduction, not relative risk reduction, that is how you decide

replysharereportpermalink
u/hazard_ratio_halstats0 points·1 year ago

number-needed-to-treat is the house dialect

replysharereportpermalink
u/nils_tullochOP1 point·1 year ago

off-label use data is different from approved-indication data

replysharereportpermalink
load more comments (2) →
u/marit_laurent-28 points·1 year ago
nope. mine was the opposite.
replysharereportpermalink
u/hamza_zielinski0 points·1 year ago

number-needed-to-treat is the house dialect

replysharereportpermalink
u/oskar_ibarra1 point·1 year ago

event rates are more informative than hazard ratios alone

replysharereportpermalink
[removed]1 point·1 year ago

[removed by moderator]

replysharereportpermalink
u/tb500_tangent1 point·1 year ago·edited

Which trial and what was the primary endpoint?

replysharereportpermalink
u/niels_norgaard1 point·1 year ago

off-label use data is different from approved-indication data

replysharereportpermalink
u/milos_trevino1 point·1 year ago·edited

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

replysharereportpermalink
u/nils_tullochOP1 point·1 year ago

number-needed-to-treat is the house dialect

replysharereportpermalink
u/sanne_laurent1 point·1 year ago

press release SELECT posts must be flaired until a publication exists

replysharereportpermalink
u/yusuf_achebe1 point·1 year ago

event rates are more informative than hazard ratios alone

replysharereportpermalink
u/hamza_weiss1 point·1 year ago

Disagree. What you are describing is consistent with SURPASS, not with what you concluded.

replysharereportpermalink
load more comments (2) →
u/careful_gradient_again1 point·1 year ago

Phase 2 TRIUMPH looked amazing. Phase 3 trials are harder. Do not anchor on phase 2 readouts.

replysharereportpermalink
u/whois_wanda1 point·1 year ago

absolute risk reduction, not relative risk reduction, that is how you decide

replysharereportpermalink
u/joaquin_trevino1 point·1 year ago

Sceptical. If this were true we would see it reflected in the data and we do not.

replysharereportpermalink
u/pancreatitis_scare213 points·1 year ago
i wish i had read this 4 months ago
replysharereportpermalink
u/careful_gradient_again125 points·1 year ago

No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.

replysharereportpermalink
u/sanne_laurent51 points·1 year ago

Titration speed is a side-effect dial far more than an efficacy dial.

replysharereportpermalink
u/trialwatch_theoMOD212 points·1 year ago

Removed a chain here. The rule is one line long and it is not negotiable.

replysharereportpermalink
u/adaeze_cabrera137 points·1 year ago

Crossposting this to c/hplc because the people who need it are not reading this community.

replysharereportpermalink
u/rina_bergstrom0 points·1 year ago

Titration speed is a side-effect dial far more than an efficacy dial.

replysharereportpermalink
u/anders_vermeulen1 point·1 year ago

Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.